Herceptin plus taxol highly effective in low-risk breast cancer
Thursday, December 12, 2013 - 12:00
in Health & Medicine
A remarkable 98.7 percent of certain lower-risk breast cancer patients were cancer free for at least three years after taking a combination of the drugs Herceptin and Taxol, a study has found.